Get started Log in

VYNT — Vyant Bio Share News

0.000.00%

Last trade - 00:00

FinancialsSpeculativeMicro CapNeutral

Market Cap
$1.23m
Enterprise Value
-$8.23m
Revenue
$0.67m

U.S. STOCKS ON THE MOVE-Cancer Genetics, Tricida, Pinterest
29/10/2020 15:03
Cancer Genetics plunges on deep-discounted stock deal
29/10/2020 13:52
Brief: Cancer Genetics, Inc. Announces $2.0 Million Bought Deal Offering
28/10/2020 22:07
Brief: Cancer Genetics Files Preliminary Prospectus Supplement Related To Common Stock Offering
28/10/2020 21:49
Brief: Cancer Genetics CFO Glenn Miles To Cease Employment As CFO Effective Nov 16, 2020
19/10/2020 14:20
Brief: Cancer Genetics And Stemonix Announce Joint Proof-Of-Concept Program
03/09/2020 13:41
Cancer Genetics jumps over two-fold on unit's merger with biotech start-up
24/08/2020 17:18
Brief: Cancer Genetics And Stemonix Sign Definitive Agreement To Merge
24/08/2020 13:25
Brief: Cancer Genetics Reports Q2 Loss Per Share $0.82
14/08/2020 13:03
Brief: Cancer Genetics Inc Files For Up To $100 Million Of Mixed Shelf Offering
26/06/2020 23:11
Brief: Cancer Genetics Q1 Loss Per Share $0.56 From Continuing Operations
24/06/2020 22:45
Brief: Cancer Genetics Reports First Quarter 2020 Financial Results
24/06/2020 22:41
Brief: Cancer Genetics Posts Q4 Loss Per Share Of $0.14
01/06/2020 13:15
Brief: Cancer Genetics Files For Non-Timely 10-K With U.S. SEC
14/05/2020 23:12
Cancer Genetics falls as co to delay filing annual report due to COVID-19
07/04/2020 16:04
Brief: Cancer Genetics To Delay Filing Of Its Annual Report
30/03/2020 23:15
NASDAQ TRADE HALT MARKET WIDE CIRCUIT BREAKER RESUMPTION AT 08:49 AM
09/03/2020 13:49
U.S. STOCKS ON THE MOVE-Tesla, Nordstrom, EyeGate, Gap, Buckle
22/11/2019 17:23
Cancer Genetics surges as co seeks strategic alternatives
20/11/2019 14:41
Brief: Cancer Genetics Q3 Earnings Per Share $0.98
20/11/2019 13:42